Further work in cells and organisms using endogenous TDP‐43 will be important to determine whether variants or post‐translational modifications that disrupt TDP‐43 self‐interaction can also alter TDP‐43 aggregation and its associated toxicity in ALS. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.